Ftse Mib
34.271,25
-0,30%
DAX
19.966,79
-0,19%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
96.570,68
-0,34%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaxart Inc (VXRT) Vaxart Inc (VXRT) Notizie

Vaxart Inc

VXRT
0,7187
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/12/202422:07EDGAR2Form 8-K - Current report
27/12/202415:21EDGAR2Form 8-K - Current report
17/12/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:01GLOBEVaxart Completes Enrollment of Sentinel Cohort in Phase 2b..
19/11/202414:00GLOBEVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
13/11/202422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:01GLOBEVaxart Provides Business Update and Reports Third Quarter..
07/11/202414:00GLOBEVaxart to Host Third Quarter 2024 Business Update and..
24/10/202414:00GLOBEVaxart to Showcase its COVID-19 and Norovirus Oral Pill..
15/10/202414:00GLOBEVaxart to Present Norovirus Data at IDWeek 2024 Underscoring..
08/10/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/10/202422:05EDGAR2Form 8-K - Current report
30/9/202423:20EDGAR2Form 8-K - Current report
30/9/202422:12GLOBEVaxart Announces Initiation of Sentinel Cohort for Phase 2b..
30/8/202414:00GLOBEVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
28/8/202414:00GLOBEVaxart Announces Publication in Vaccines of Preclinical Data..
08/8/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:01GLOBEVaxart Provides Business Update and Reports Second Quarter..
02/8/202414:00GLOBEVaxart to Host Second Quarter 2024 Business Update and..
20/6/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:05GLOBEVaxart Provides Business Update
17/6/202412:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202412:03EDGAR2Form 8-K - Current report
14/6/202401:07GLOBEVaxart Announces $40 Million Underwritten Offering of Common..
13/6/202423:26EDGAR2Form 8-K - Current report
13/6/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:15GLOBEVaxart Receives BARDA-Funded Project NextGen Award Valued Up..
13/6/202422:07EDGAR2Form 8-K - Current report
12/6/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:01GLOBEVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
13/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:03EDGAR2Form 8-K - Current report
13/5/202422:01GLOBEVaxart Provides Business Update and Reports First Quarter..
13/5/202413:10IHMARKETNEWSU.S. Futures Climb Amid High Expectations for Inflation..
07/5/202414:00GLOBEVaxart to Host First Quarter 2024 Business Update and..
30/4/202414:00GLOBEVaxart Announces Positive Results for Its Bivalent Norovirus..
27/3/202413:00GLOBEVaxart to Present at World Vaccine Congress Washington 2024..
20/3/202413:00GLOBEVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
14/3/202421:01GLOBEVaxart Provides Business Update and Reports Full Year 2023..
14/3/202412:41IHMARKETNEWSU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil..
07/3/202414:00GLOBEVaxart to Host Full Year 2023 Business Update and Financial..
06/3/202415:23EDGAR2Form 8-K - Current report
06/3/202414:00GLOBEVaxart, Inc. Appoints Steven Lo as President, Chief..
29/2/202422:30EDGAR2Form 8-K - Current report
15/2/202422:10EDGAR2Form 8-K - Current report
13/2/202423:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: Min: Max:
Chiusura: 0,7187

La tua Cronologia

NASDAQ
VXRT
Vaxart
AMEX
CCX
BIT
S31312
Societe Generale Effekten
BIT
S29629
Societe Generale Effekten
TG
EDMU
Ishares Iv
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network